WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS

DRINKING WATER PRODUCTS

EPRO™ Commercial Systems are designed to maximize water purification efficiency. Available models offer a choice of flow rates and configurations for removal of dissolved solids and other impurities from tap water or brackish water. Purified high-quality water is supplied to your application at existing point of use.

The NeoTech D338™ is specially designed to disinfect water and is an essential component in advanced oxidation processes.

The DE NORA TETRA® ABF bioactive filter combines ozone generation with biologically active filtration for use in municipal water applications. The process targets micropollutant reduction and reduces disinfection byproducts in drinking water and potable reuse applications.

Meeting the demand for clean water has never been more challenging. Communities around the world are facing a growing water stress – an insufficient supply, in terms of water quality or water quantity – and often both. Many are turning to potable reuse and drinking water remediation to meet these demands. The TrojanUVFlex®AOP can be part of the solution. This UV advanced oxidation system destroys a range of chemical contaminants while simultaneously providing final treatment, helping municipalities relying on lower quality water sources to continue producing high-quality potable drinking water.

Based on proven electrodialysis reversal (EDR) technology, the END® system transforms two key components of traditional EDR to deliver maximum recovery with minimum energy consumption in numerous brackish water treatment applications.

Faced with rising water scarcity, advanced facilities are utilizing UV advanced oxidation to destroy persistent chemical micropollutants and achieve stringent pathogen disinfection in a single step, ensuring a highly pure, reliable potable water supply.

VIEWS ON THE LATEST REGS

  • The U.S. EPA is testing a new procedural strategy to remove four PFAS drinking‑water limits from ongoing litigation, asking the D.C. Circuit Court of Appeals to invalidate those limits on the grounds that the EPA itself committed a procedural misstep when issuing the 2024 PFAS rule.
  • Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
  • In this Q&A, Dr. Elke Süss of Metrohm addresses the urgent need for haloacetic acid testing in response to “one of the most significant updates to EU drinking water monitoring in recent years.”
  • With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
  • A Q&A to explain and resolve issues confronting water suppliers as they endeavor to comply with the monitoring requirements of federal PFAS regulations.

MORE WATER INDUSTRY FEATURES

  • Routine sensor maintenance silently drains utility workforce capacity through constant recalibration, reagent refills, and travel time. Transitioning to low-maintenance monitoring technology reclaims thousands of operator hours, allowing short-handed crews to focus on vital system infrastructure priorities.

  • Explore how rapid equipment replacement and peristaltic pump technology prevented regulatory violations at a major sanitation district. Learn how high-stakes infrastructure failures were resolved through strategic engineering support to ensure continuous delivery of safe water.

  • An optimized in vitro transcription (IVT) platform enables scalable, high-yield, and cost-efficient mRNA therapeutic production by leveraging data-driven process optimization and enzyme innovation to overcome key manufacturing challenges.

  • Learn how ECI consultants radically reduced costs and wastes while improving working conditions and ensuring compliance using 900 Series Monitor/Controllers.